DHIVY

Peak

carbidopa levodopa

NDAORALTABLET

Approved

Nov 2021

Lifecycle

Peak

Competitive Pressure

0/100

Mechanism of Action

DOPA Decarboxylase Inhibitors

Pharmacologic Class:

Aromatic Amino Acid Decarboxylation Inhibitor

Indications (4)

Parkinson's disease post-encephalitic parkinsonism symptomatic parkinsonism manganese intoxication ( )

Loss of Exclusivity

LOE Date

Mar 28, 2039

159 months away

Patent Expiry

Mar 28, 2039

Patent Records (3)

Patent #	Expiry	Type	Use Code
11033521	Mar 28, 2039	Product	U-3305
11439613	Mar 28, 2039		U-3557
11819485	Mar 28, 2039		U-3557

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers